Jeffrey Leiden
North America, Massachusetts, United States, Boston
Description
Dr. Jeff Leiden is the Executive Chairman of Vertex Pharmaceuticals since April 2020. Previously he served as CEO and President since Februa...
Investor Profile
Jeffrey Leiden has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States, The Netherlands.
- Strong thematic focus on Health Care, Medical, Mental Health.
Stage Focus
- Series B (33%)
- Series A (33%)
- Seed (33%)
Country Focus
- United States (67%)
- The Netherlands (33%)
Industry Focus
- Health Care
- Medical
- Mental Health
- Food And Beverage
- Food Processing
- Innovation Management
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
